Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001

Clinical trial NCT01429064 · COMPLETED

Trial details

NCT number: NCT01429064
Sponsor: Orion Corporation, Orion Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2011-06-01
Primary completion: 2015-11-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.